| JYSB2400205 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2024-09-11 | | | | | view |
| JYSB2300117 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | | | | view |
| CXSS2101019 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2021-08-05 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JXSL2400217 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-11-11 | | | | | view |
| JYSB2400081 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-04-08 | | | | | view |
| JXSS2200027 | 帕妥珠单抗曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-07-27 | | | | | view |
| JYSB2400171 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-08-03 | | Roche Pharma (Schweiz) AG | | | view |
| CXSS2300027 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2023-04-27 | | QILU Pharmaceutical Co Ltd | | | view |
| JXSL0500008 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(1) | Import Drug Application | 2005-04-01 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2005-11-16 | view |
| CYSB2400265 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-09 | | QILU Pharmaceutical Co Ltd | | | view |
| JXSS2300089 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-12-12 | | | | | view |
| JYSB2200017 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2022-02-11 | | | | | view |
| JYSZ2400033 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | | | | view |
| CYSB2101224 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | | | | view |
| CYSB2400292 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-11-09 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JXSS2400013 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(3.1) | Import Drug Application | 2024-02-08 | | | | | view |
| CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JYSB2400139 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-06-28 | | | | | view |
| JTS2200110 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2022-12-31 | | | | | view |
| JXSL0500007 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(1) | Import Drug Application | 2005-04-01 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2005-11-16 | view |
